Comparison tool
Compare peptides
Pick up to three compounds. Useful for deciding whether two peptides in a stack actually do different things, or whether you're paying twice for the same pathway.
Select up to three (1/3)
| Attribute | |
|---|---|
| Category | Metabolic |
| Evidence grade | Limited |
| Also known as | 5-amino-1-methylquinolinium |
| Mechanism | Inhibits nicotinamide N-methyltransferase (NNMT), an enzyme overexpressed in obese adipose tissue. Blocking it raises intracellular NAD+ and SAM, increasing energy expenditure in fat cells. |
| Key benefits | Reduced fat-cell size in rodent studies · Increased cellular NAD+ · Oral bioavailability — no injections |
| Side effects | Insomnia if dosed late · Mild GI upset · Unknown long-term profile |
| Half-life | Estimated several hours |
| Administration | Oral capsule |
| Dosing overview | 50–150 mg once daily in the morning |
| Storage | Cool, dry place away from light |
| Legal status | Sold as a research compound; not an approved drug or dietary supplement. |
Dosing figures reflect published literature and commonly reported community protocols. They are informational only.